SCHEMBL7255709

SCHEMBL7255709

O=C(Nc1ccc2[nH]ncc2c1)c1cc(NCCO)c(F)cc1F

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 3/20 0.58
JAK1 P23458 2/20 0.58
NPC1 O15118 7/20 0.56
RAB9A P51151 7/20 0.56
ROCK2 O75116 4/20 0.53
ROCK1 Q13464 4/20 0.53
RPS6KB1 P23443 3/20 0.53
MAP4K4 O95819 2/20 0.53
CLK2 P49760 2/20 0.53
DYRK1A Q13627 2/20 0.53
CLK4 Q9HAZ1 2/20 0.53
DYRK3 O43781 1/20 0.53
CSNK2A1 P68400 1/20 0.53
MKNK2 Q9HBH9 1/20 0.53
MAOB P27338 4/20 0.53
HPGD P15428 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
PRKD3 O94806 1/20 0.50
PRKG1 Q13976 1/20 0.50
PRKD2 Q9BZL6 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7256698 0.93 NPC1 (0.61) JAK2JAK1NPC1RAB9AROCK2
SCHEMBL7255808 0.88 JAK2 (0.57) JAK2JAK1NPC1RAB9AROCK2
SCHEMBL7255640 0.85 JAK2 (0.52) JAK2JAK1NPC1RAB9AROCK2
SCHEMBL7261149 0.84 NPC1 (0.68) JAK2JAK1NPC1RAB9AROCK2
SCHEMBL7259291 0.84 ROCK1 (0.58) JAK2JAK1NPC1RAB9AROCK2
SCHEMBL7256479 0.83 LRRK2 (0.53) JAK2JAK1NPC1RAB9AROCK2
SCHEMBL7261177 0.82 JAK2 (0.48) JAK2JAK1NPC1RAB9AROCK2
SCHEMBL7256998 0.81 JAK2 (0.56) JAK2JAK1NPC1RAB9AROCK2
SCHEMBL7261196 0.81 NPC1 (0.57) JAK2JAK1NPC1RAB9AROCK2
SCHEMBL7255625 0.77 NPC1 (0.57) JAK2JAK1NPC1RAB9AROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003002518-A1 NOVEL 2,4-DIFLUOROBENZAMIDE DERIVATIVES AS ANTIVIRAL AGENTS DONG HWA PHARM. IND. CO., LTD. (KR) 2003-01-09 WO disclosed